The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. BridgeBio Pharma Inc shares valued at $613,826 were sold by Kumar Neil on Nov 19 ’24. At $22.41 per share, Kumar Neil sold 27,389 shares. The insider’s holdings dropped to 4,897,443 shares worth approximately $112.84 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, STEPHENSON BRIAN C sold 4,156 shares, netting a total of over 93,137 in proceeds. Following the sale of shares at $22.41 each, the insider now holds 93,758 shares.
Before that, BRIAN STEPHENSON had added 4,156 shares to its account. In a trade valued at $92,887, the Officer bought BridgeBio Pharma Inc shares for $22.35 each.
As published in their initiating research note from Scotiabank on October 16, 2024, BridgeBio Pharma Inc [BBIO] has been a Sector outperform. Analysts at Oppenheimer started covering the stock with ‘”a Perform”‘ outlook in a report released in early October. As of September 04, 2024, Piper Sandler has initiated its “an Overweight” rating for BBIO.
Analyzing BBIO Stock Performance
During the last five days, there has been a drop of approximately -7.06%. Over the course of the year, BridgeBio Pharma Inc shares have dropped approximately -42.93%. Shares of the company reached a 52-week high of $41.04 on 02/15/24 and a 52-week low of $21.62 on 06/24/24. A 50-day SMA is recorded $25.09, while a 200-day SMA reached $27.36. Nevertheless, trading volume fell to 1.39 million shares from 2.15 million shares the previous day.
Support And Resistance Levels for BridgeBio Pharma Inc (BBIO)
According to the 24-hour chart, there is a support level at 22.34, which, if violated, would cause prices to drop to 21.64. In the upper region, resistance lies at 23.45. The next price resistance is at 23.86. RSI (Relative Strength Index) is 40.41 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.08, which suggests the price will decrease in the coming days. Percent R is at 77.44%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
